Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Drug discovery has long been criticized for its slow, costly, and failure-prone nature. Traditional approaches, particularly ...

Drug discovery startup Synfini Inc. said today it has closed on an $8.9 million expansion funding round led by JSL Health ...

The two companies collaborated on research showing quantum computing could greatly aid the design of mRNA-based medicines and ...

Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter "Elix") is pleased to announce that its AI drug discovery platform, Elix Discovery™ ( has been adopted by Eisai Co., Ltd. (Headquarters: ...

The model is trained on a massive dataset over 200 milliseconds of molecular dynamics simulations and half a million protein ...

Revolution Medicines' proprietary data will train a bespoke version of NeuralPLexer, an AI model for protein-ligand ...

Biology was created by nature and therefore harder to ‘manipulate’, Huang said at the China International Supply Chain Expo ...

Ambitious study will profile thousands of tumor samples to uncover novel biomarkers and therapeutic targets for cancer and ...

Conversations with entrepreneurs, technologists, and researchers on emerging technologies and the importance of STEM in drug ...

AI meets molecular dynamics in Divamics’ latest breakthroughs, accelerating new therapies for complex metabolic conditions.

UC Santa Barbara researchers and collaborators from campus biotech spinoff Integrated Biosciences, as well as Harvard, MIT ...